glp 1 and pregnancy Reconciling GLP-1s Pancreatitis GLP-1 has changed the conversation

The evidence base for peptides in eczema is substantially thinner than for conventional treatments

A September 2022 study of 127 adults published in the journal JCI Insight suggested that people with both obesity and alcohol use disorder who were treated with a GLP-1 drug called exenatide (Byetta, Bydureon) drank dramatically less than those who received only a placebo drug

From an evidence-based standpoint, the answer remains no

Methods: Relevant articles published before January 2025 were retrieved from Google Scholar, PubMed, ScienceDirect, Scopus, Web of Science, Springer, and official sources

Plus, it takes years for many trials and studies to be completed